Close Menu

NEW YORK (GenomeWeb) – Genome Canada announced today that it has partnered with various Canadian provinces and organizations to invest a total of C$255 million ($204.4 million) in two initiatives advancing precision medicine and genomic technology development.

Under the first initiative, Genome Canada, the Canadian Institutes of Health Research, and other partners will provide C$162 million over four years to support 15 precision medicine and genomics projects underway across Canada.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.